Schneider Susanne A, Udani Vrajesh, Sankhla Charulata Sawant, Bhatia Kailash P
Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London, United Kingdom.
Mov Disord. 2009 Jun 15;24(8):1226-9. doi: 10.1002/mds.22532.
Adverse events of dopamine-blocking agents include acute dystonic reactions and oculogyric crises (OGCs). OGCs may be recurrent on maintenance of or re-exposure to the drug. Thus, complete withdrawal is recommended. Recurrent episodes of acute dystonia despite withdrawal and the lack of further exposure to antidopaminergic agents are usually not seen. Here, we report three cases with recurrent OGCs despite complete withdrawal of neuroleptics. Triggering or priming factors were a single dose of haloperidol in two cases and a single dose of metoclopramide in one case. Episodes reoccurred spontaneously, but responded to anticholinergics. The pathomechanisms of acute dystonic reactions and OGCs remain unclear. Parallels to levodopa-induced dyskinesias in Parkinson's disease, as well as to dopa-responsive dystonia, paroxysmal dyskinesias, and channelopathies are discussed here. Whether there is a genetic susceptibility or some other reason for only some patients developing this phenomenon remains unclear.
多巴胺阻滞剂的不良事件包括急性肌张力障碍反应和动眼危象(OGCs)。OGCs在维持用药或再次接触该药物时可能会复发。因此,建议完全停药。通常不会出现尽管停药且不再接触抗多巴胺能药物但急性肌张力障碍仍反复发作的情况。在此,我们报告3例患者,尽管已完全停用抗精神病药物,但仍反复出现OGCs。触发或引发因素在2例患者中为单剂量氟哌啶醇,在1例患者中为单剂量甲氧氯普胺。发作自发复发,但对抗胆碱能药物有反应。急性肌张力障碍反应和OGCs的发病机制仍不清楚。本文讨论了与帕金森病中左旋多巴诱发的运动障碍以及多巴反应性肌张力障碍、发作性运动障碍和离子通道病的相似之处。仅部分患者出现这种现象是存在遗传易感性还是其他原因仍不清楚。